Hi @SalmonKing
It is now a waiting game
I remain confident in the science
I have continued to top up at these depressed levels
We have agreements in place with Genentech and Merck which the company refuses to comment on (confidentiality)
There are completed phase 2 trials with ongoing discussions with potential partners for multiple cancer indications
We have commercialised products in the market which up until now have performed abysfully. In regards to this the company (as stated in previous announcement to shareholders) is working hard behind the scenes in order to improve revenues
I remain confident for the future of Starpharma and believe we will be in a far better position before end of calendar year 2024
Hi @SalmonKing It is now a waiting game I remain confident in...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.7¢ | $111.3K | 1.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43696 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 130967 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |